Login / Signup

Adjunctive treatment with infliximab in pediatric immunoglobulin A (IgA) vasculitis: A case report.

Barbara CastelliEdoardo MarraniEleonora FuscoCaporalini ChiaraIlaria PagniniGabriele Simonini
Published in: Pediatric dermatology (2022)
Immunoglobulin A vasculitis (IgAV) is the most common childhood vasculitis affecting small vessels. No clear recommendations are available for severe pediatric cases, and until now, anti-TNF agents have had a limited role in IgAV management. In this report, we describe a pediatric case of severe IgAV, successfully treated with combined therapy including the anti-TNF, infliximab.
Keyphrases
  • rheumatoid arthritis
  • early onset
  • ulcerative colitis
  • stem cells
  • drug induced
  • early life
  • cell therapy